Copyright Reports & Markets. All rights reserved.

Global Prescription Arthritis Medications Market Growth 2019-2024

Request for Sample of this report
Buy now

Table of Contents

    2019-2024 Global Prescription Arthritis Medications Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Prescription Arthritis Medications Consumption 2014-2024
        • 2.1.2 Prescription Arthritis Medications Consumption CAGR by Region
      • 2.2 Prescription Arthritis Medications Segment by Type
        • 2.2.1 Oral
        • 2.2.2 Topical
      • 2.3 Prescription Arthritis Medications Consumption by Type
        • 2.3.1 Global Prescription Arthritis Medications Consumption Market Share by Type (2014-2019)
        • 2.3.2 Global Prescription Arthritis Medications Revenue and Market Share by Type (2014-2019)
        • 2.3.3 Global Prescription Arthritis Medications Sale Price by Type (2014-2019)
      • 2.4 Prescription Arthritis Medications Segment by Application
        • 2.4.1 Hospital Pharmacies
        • 2.4.2 Online Pharmacies
        • 2.4.3 Retail Pharmacies
      • 2.5 Prescription Arthritis Medications Consumption by Application
        • 2.5.1 Global Prescription Arthritis Medications Consumption Market Share by Application (2014-2019)
        • 2.5.2 Global Prescription Arthritis Medications Value and Market Share by Application (2014-2019)
        • 2.5.3 Global Prescription Arthritis Medications Sale Price by Application (2014-2019)

      3 Global Prescription Arthritis Medications by Players

      • 3.1 Global Prescription Arthritis Medications Sales Market Share by Players
        • 3.1.1 Global Prescription Arthritis Medications Sales by Players (2017-2019)
        • 3.1.2 Global Prescription Arthritis Medications Sales Market Share by Players (2017-2019)
      • 3.2 Global Prescription Arthritis Medications Revenue Market Share by Players
        • 3.2.1 Global Prescription Arthritis Medications Revenue by Players (2017-2019)
        • 3.2.2 Global Prescription Arthritis Medications Revenue Market Share by Players (2017-2019)
      • 3.3 Global Prescription Arthritis Medications Sale Price by Players
      • 3.4 Global Prescription Arthritis Medications Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global Prescription Arthritis Medications Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players Prescription Arthritis Medications Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 Prescription Arthritis Medications by Regions

      • 4.1 Prescription Arthritis Medications by Regions
        • 4.1.1 Global Prescription Arthritis Medications Consumption by Regions
        • 4.1.2 Global Prescription Arthritis Medications Value by Regions
      • 4.2 Americas Prescription Arthritis Medications Consumption Growth
      • 4.3 APAC Prescription Arthritis Medications Consumption Growth
      • 4.4 Europe Prescription Arthritis Medications Consumption Growth
      • 4.5 Middle East & Africa Prescription Arthritis Medications Consumption Growth

      5 Americas

      • 5.1 Americas Prescription Arthritis Medications Consumption by Countries
        • 5.1.1 Americas Prescription Arthritis Medications Consumption by Countries (2014-2019)
        • 5.1.2 Americas Prescription Arthritis Medications Value by Countries (2014-2019)
      • 5.2 Americas Prescription Arthritis Medications Consumption by Type
      • 5.3 Americas Prescription Arthritis Medications Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Prescription Arthritis Medications Consumption by Countries
        • 6.1.1 APAC Prescription Arthritis Medications Consumption by Countries (2014-2019)
        • 6.1.2 APAC Prescription Arthritis Medications Value by Countries (2014-2019)
      • 6.2 APAC Prescription Arthritis Medications Consumption by Type
      • 6.3 APAC Prescription Arthritis Medications Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Prescription Arthritis Medications by Countries
        • 7.1.1 Europe Prescription Arthritis Medications Consumption by Countries (2014-2019)
        • 7.1.2 Europe Prescription Arthritis Medications Value by Countries (2014-2019)
      • 7.2 Europe Prescription Arthritis Medications Consumption by Type
      • 7.3 Europe Prescription Arthritis Medications Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Prescription Arthritis Medications by Countries
        • 8.1.1 Middle East & Africa Prescription Arthritis Medications Consumption by Countries (2014-2019)
        • 8.1.2 Middle East & Africa Prescription Arthritis Medications Value by Countries (2014-2019)
      • 8.2 Middle East & Africa Prescription Arthritis Medications Consumption by Type
      • 8.3 Middle East & Africa Prescription Arthritis Medications Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Channels
        • 10.1.2 Indirect Channels
      • 10.2 Prescription Arthritis Medications Distributors
      • 10.3 Prescription Arthritis Medications Customer

      11 Global Prescription Arthritis Medications Market Forecast

      • 11.1 Global Prescription Arthritis Medications Consumption Forecast (2019-2024)
      • 11.2 Global Prescription Arthritis Medications Forecast by Regions
        • 11.2.1 Global Prescription Arthritis Medications Forecast by Regions (2019-2024)
        • 11.2.2 Global Prescription Arthritis Medications Value Forecast by Regions (2019-2024)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global Prescription Arthritis Medications Forecast by Type
      • 11.8 Global Prescription Arthritis Medications Forecast by Application

      12 Key Players Analysis

      • 12.1 Abbott
        • 12.1.1 Company Details
        • 12.1.2 Prescription Arthritis Medications Product Offered
        • 12.1.3 Abbott Prescription Arthritis Medications Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.1.4 Main Business Overview
        • 12.1.5 Abbott News
      • 12.2 Amgen
        • 12.2.1 Company Details
        • 12.2.2 Prescription Arthritis Medications Product Offered
        • 12.2.3 Amgen Prescription Arthritis Medications Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.2.4 Main Business Overview
        • 12.2.5 Amgen News
      • 12.3 Boehringer Ingelheim
        • 12.3.1 Company Details
        • 12.3.2 Prescription Arthritis Medications Product Offered
        • 12.3.3 Boehringer Ingelheim Prescription Arthritis Medications Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.3.4 Main Business Overview
        • 12.3.5 Boehringer Ingelheim News
      • 12.4 Horizon Pharma
        • 12.4.1 Company Details
        • 12.4.2 Prescription Arthritis Medications Product Offered
        • 12.4.3 Horizon Pharma Prescription Arthritis Medications Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.4.4 Main Business Overview
        • 12.4.5 Horizon Pharma News
      • 12.5 Novartis
        • 12.5.1 Company Details
        • 12.5.2 Prescription Arthritis Medications Product Offered
        • 12.5.3 Novartis Prescription Arthritis Medications Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.5.4 Main Business Overview
        • 12.5.5 Novartis News
      • 12.6 Pfizer
        • 12.6.1 Company Details
        • 12.6.2 Prescription Arthritis Medications Product Offered
        • 12.6.3 Pfizer Prescription Arthritis Medications Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.6.4 Main Business Overview
        • 12.6.5 Pfizer News
      • 12.7 Regeneron
        • 12.7.1 Company Details
        • 12.7.2 Prescription Arthritis Medications Product Offered
        • 12.7.3 Regeneron Prescription Arthritis Medications Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.7.4 Main Business Overview
        • 12.7.5 Regeneron News

      ...

        13 Research Findings and Conclusion

        Arthritis medicines are generally very effective in helping people with arthritis to manage joint pain and other symptoms.

        According to this study, over the next five years the Prescription Arthritis Medications market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Prescription Arthritis Medications business, shared in Chapter 3.

        This report presents a comprehensive overview, market shares, and growth opportunities of Prescription Arthritis Medications market by product type, application, key manufacturers and key regions and countries.

        This study considers the Prescription Arthritis Medications value and volume generated from the sales of the following segments:

        Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
        Oral
        Topical
        Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
        Hospital Pharmacies
        Online Pharmacies
        Retail Pharmacies

        This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
        Americas
        United States
        Canada
        Mexico
        Brazil
        APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
        Europe
        Germany
        France
        UK
        Italy
        Russia
        Spain
        Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

        The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
        Abbott
        Amgen
        Boehringer Ingelheim
        Horizon Pharma
        Novartis
        Pfizer
        Regeneron
        ...

        In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

        Research objectives
        To study and analyze the global Prescription Arthritis Medications consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
        To understand the structure of Prescription Arthritis Medications market by identifying its various subsegments.
        Focuses on the key global Prescription Arthritis Medications manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
        To analyze the Prescription Arthritis Medications with respect to individual growth trends, future prospects, and their contribution to the total market.
        To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
        To project the consumption of Prescription Arthritis Medications submarkets, with respect to key regions (along with their respective key countries).
        To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
        To strategically profile the key players and comprehensively analyze their growth strategies.

        Buy now